The biology of CD45 and its use as a therapeutic target.
about
The cancer stem cell: evidence for its origin as an injured autoreactive T cellNeurotherapeutic effect of cord blood derived CD45+ hematopoietic cells in mice after traumatic brain injury.Pretargeted radioimmunotherapy for hematologic and other malignanciesEnrichment of outgrowth endothelial cells in high and low colony-forming cultures from peripheral blood progenitors.Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation culturesA Depleting Anti-CD45 Monoclonal Antibody as Isolated Conditioning for Bone Marrow Transplantation in the Rat.CD45RO enriches for activated, highly mutated human germinal center B cellsα-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After 211At-Radioimmunotherapy for Hematopoietic Cell Transplantation.Loss of naïve (CD45RA+) CD4+ lymphocytes during pediatric infection with feline immunodeficiency virus.Profiling CD antigens on leukaemias with an antibody microarray.Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin.A subset of CD45+/CD19 - cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma.Gene expression analysis of myeloid and lymphoid lineage markers during mouse haematopoiesis.Interferon gamma causes olfactory dysfunction without concomitant neuroepithelial damage.Divergent effects of losartan and metoprolol on cardiac remodeling, c-kit+ cells, proliferation and apoptosis in the left ventricle after myocardial infarctionA CD45-based barcoding approach to multiplex mass-cytometry (CyTOF).Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival.Crystal structure of the human B-form low molecular weight phosphotyrosyl phosphatase at 1.6-A resolution.Anti-CD45RB and donor-specific spleen cells transfusion inhibition allograft skin rejection mediated by memory T cells.Congenital immature pure erythroid leukemia with E-cadherin expression.Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus.Myeloid Conditioning with c-kit-Targeted CAR-T Cells Enables Donor Stem Cell Engraftment.Haploidentical stem cell transplantation augmented by CD45RA negative lymphocytes provides rapid engraftment and excellent tolerability.
P2860
Q25256839-D8945350-CB77-45CC-A2C6-564CDDF86E8CQ34043822-BCFF996E-BDDD-4219-9649-1AFA79C32889Q34113941-A3F34362-CC0C-4742-9699-44E7430F58D5Q34193750-D8C2A23A-60C7-4286-ABB1-CF5BCFC42BC7Q35849083-7683B0FC-62A7-4966-82FD-B62AC8304B95Q36006801-82BF84E7-2C6E-4088-885A-3ABB6331D846Q36360430-8E9F002F-A656-4EAD-AC3F-63DBCD09D14CQ36362587-ECBAEA24-F572-480C-80BA-6420C93EAD14Q36696211-115F123C-9CFE-4EBF-8919-94BBC82F0853Q37418300-0E0C7B18-F954-4555-8A54-8C411DE6B4DFQ37527541-4D1CFE5E-E406-42D6-9AF5-34D6CF9499D4Q39032927-EC2AB4FE-5842-448B-AF6D-4559688F62B2Q40240857-1FD5705B-A0AA-4D06-9E81-DCC765FA2DEFQ42036286-05E563F0-6DB8-4B04-98D9-D3955133A1AEQ42123922-4C74D5A9-06AB-4379-B852-B596617596DAQ43142483-DAB22E6B-9569-471C-B2BB-35931595042BQ44052238-A3EF5DFB-F2D9-4E5A-9FE8-53AA76E74831Q46778003-0E2145C7-7FA6-4460-8993-5A42FB74E5E2Q48004570-467F7906-2325-46E2-A30A-901B572E0396Q50992983-4422D7DE-85DE-4885-B6A8-1BF91BDAA782Q51719344-D99F697B-ED20-4E24-9C3E-53E9FD177876Q52603959-39F1461D-91AC-4962-B777-5422EFCE352EQ53652856-8938F4D9-0D7B-4D8D-B3CB-0E98036805C5
P2860
The biology of CD45 and its use as a therapeutic target.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The biology of CD45 and its use as a therapeutic target.
@ast
The biology of CD45 and its use as a therapeutic target.
@en
The biology of CD45 and its use as a therapeutic target.
@nl
type
label
The biology of CD45 and its use as a therapeutic target.
@ast
The biology of CD45 and its use as a therapeutic target.
@en
The biology of CD45 and its use as a therapeutic target.
@nl
prefLabel
The biology of CD45 and its use as a therapeutic target.
@ast
The biology of CD45 and its use as a therapeutic target.
@en
The biology of CD45 and its use as a therapeutic target.
@nl
P2093
P2860
P1433
P1476
The biology of CD45 and its use as a therapeutic target.
@en
P2093
Hans J Schlitt
John E J Rasko
Marc H Dahlke
Stephen R Larsen
P2860
P304
P356
10.1080/1042819031000151932
P577
2004-02-01T00:00:00Z